{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T08:03:12Z","timestamp":1791273792923,"version":"4.1.0"},"reference-count":32,"publisher":"Wiley","issue":"8","license":[{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100013995","name":"Sanofi Genzyme","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100013995","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100017117","name":"Denali Therapeutics","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100017117","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ascpt.onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Clinical Translational Sci"],"published-print":{"date-parts":[[2022,8]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>RIPK1 is a master regulator of inflammatory signaling and cell death and increased RIPK1 activity is observed in human diseases, including Alzheimer\u2019s disease (AD) and amyotrophic lateral sclerosis (ALS). RIPK1 inhibition has been shown to protect against cell death in a range of preclinical cellular and animal models of diseases. SAR443060 (previously DNL747) is a selective, orally bioavailable, central nervous system (CNS)\u2013penetrant, small\u2010molecule, reversible inhibitor of RIPK1. In three early\u2010stage clinical trials in healthy subjects and patients with AD or ALS (NCT03757325 and NCT03757351), SAR443060 distributed into the cerebrospinal fluid (CSF) after oral administration and demonstrated robust peripheral target engagement as measured by a reduction in phosphorylation of RIPK1 at serine 166 (pRIPK1) in human peripheral blood mononuclear cells compared to baseline. RIPK1 inhibition was generally safe and well\u2010tolerated in healthy volunteers and patients with AD or ALS. Taken together, the distribution into the CSF after oral administration, the peripheral proof\u2010of\u2010mechanism, and the safety profile of RIPK1 inhibition to date, suggest that therapeutic modulation of RIPK1 in the CNS is possible, conferring potential therapeutic promise for AD and ALS, as well as other neurodegenerative conditions. However, SAR443060 development was discontinued due to long\u2010term nonclinical toxicology findings, although these nonclinical toxicology signals were not observed in the short duration dosing in any of the three early\u2010stage clinical trials. The dose\u2010limiting toxicities observed for SAR443060 preclinically have not been reported for other RIPK1\u2010inhibitors, suggesting that these toxicities are compound\u2010specific (related to SAR443060) rather than RIPK1 pathway\u2010specific.<\/jats:p>","DOI":"10.1111\/cts.13317","type":"journal-article","created":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T16:25:06Z","timestamp":1654100706000},"page":"2010-2023","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":112,"title":["Safety, pharmacokinetics and target engagement of novel\n                    <scp>RIPK1<\/scp>\n                    inhibitor\n                    <scp>SAR443060<\/scp>\n                    (\n                    <scp>DNL747<\/scp>\n                    ) for neurodegenerative disorders: Randomized,\n                    <scp>placebo\u2010controlled<\/scp>\n                    ,\n                    <scp>double\u2010blind<\/scp>\n                    phase I\/Ib studies in healthy subjects and patients"],"prefix":"10.1111","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7199-7301","authenticated-orcid":false,"given":"Maurits F. J. M.","family":"Vissers","sequence":"first","affiliation":[{"name":"Centre for Human Drug Research  Leiden The Netherlands"},{"name":"Leiden University Medical Center  Leiden The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7202-5088","authenticated-orcid":false,"given":"Jules A. A. C.","family":"Heuberger","sequence":"additional","affiliation":[{"name":"Centre for Human Drug Research  Leiden The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4655-6667","authenticated-orcid":false,"given":"Geert Jan","family":"Groeneveld","sequence":"additional","affiliation":[{"name":"Centre for Human Drug Research  Leiden The Netherlands"},{"name":"Leiden University Medical Center  Leiden The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jerome","family":"Oude Nijhuis","sequence":"additional","affiliation":[{"name":"Department of Neurology and Alzheimer Center, University of Groningen University Medical Center Groningen  Groningen The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter Paul","family":"De Deyn","sequence":"additional","affiliation":[{"name":"Department of Neurology and Alzheimer Center, University of Groningen University Medical Center Groningen  Groningen The Netherlands"},{"name":"Laboratory of Neurochemistry and Behavior, Department of Biomedical Sciences and Institute Born\u2010Bunge University of Antwerp  Antwerp Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salah","family":"Hadi","sequence":"additional","affiliation":[{"name":"PRA Health Sciences  Groningen The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey","family":"Harris","sequence":"additional","affiliation":[{"name":"Denali Therapeutics Inc.  South San Francisco California USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard M.","family":"Tsai","sequence":"additional","affiliation":[{"name":"Denali Therapeutics Inc.  South San Francisco California USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andres","family":"Cruz\u2010Herranz","sequence":"additional","affiliation":[{"name":"Denali Therapeutics Inc.  South San Francisco California USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fen","family":"Huang","sequence":"additional","affiliation":[{"name":"Denali Therapeutics Inc.  South San Francisco California USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent","family":"Tong","sequence":"additional","affiliation":[{"name":"Denali Therapeutics Inc.  South San Francisco California USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca","family":"Erickson","sequence":"additional","affiliation":[{"name":"Denali Therapeutics Inc.  South San Francisco California USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuda","family":"Zhu","sequence":"additional","affiliation":[{"name":"Denali Therapeutics Inc.  South San Francisco California USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kimberly","family":"Scearce\u2010Levie","sequence":"additional","affiliation":[{"name":"Denali Therapeutics Inc.  South San Francisco California USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Hsiao\u2010Nakamoto","sequence":"additional","affiliation":[{"name":"Denali Therapeutics Inc.  South San Francisco California USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyan","family":"Tang","sequence":"additional","affiliation":[{"name":"Denali Therapeutics Inc.  South San Francisco California USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Megan","family":"Chang","sequence":"additional","affiliation":[{"name":"Denali Therapeutics Inc.  South San Francisco California USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian M.","family":"Fox","sequence":"additional","affiliation":[{"name":"Denali Therapeutics Inc.  South San Francisco California USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony A.","family":"Estrada","sequence":"additional","affiliation":[{"name":"Denali Therapeutics Inc.  South San Francisco California USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert J.","family":"Pomponio","sequence":"additional","affiliation":[{"name":"Sanofi Genzyme  Cambridge Massachusetts USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miguel","family":"Alonso\u2010Alonso","sequence":"additional","affiliation":[{"name":"Sanofi Genzyme  Cambridge Massachusetts USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moshe","family":"Zilberstein","sequence":"additional","affiliation":[{"name":"Sanofi Genzyme  Cambridge Massachusetts USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nazem","family":"Atassi","sequence":"additional","affiliation":[{"name":"Sanofi Genzyme  Cambridge Massachusetts USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew D.","family":"Troyer","sequence":"additional","affiliation":[{"name":"Denali Therapeutics Inc.  South San Francisco California USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carole","family":"Ho","sequence":"additional","affiliation":[{"name":"Denali Therapeutics Inc.  South San Francisco California USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2022,6]]},"reference":[{"key":"e_1_2_13_2_1","doi-asserted-by":"publisher","DOI":"10.1002\/j.1460-2075.1996.tb01007.x"},{"key":"e_1_2_13_3_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrm3683"},{"key":"e_1_2_13_4_1","doi-asserted-by":"publisher","DOI":"10.1038\/nchembio711"},{"key":"e_1_2_13_5_1","doi-asserted-by":"publisher","DOI":"10.1038\/nchembio.83"},{"key":"e_1_2_13_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuron.2014.01.011"},{"key":"e_1_2_13_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2015.02.052"},{"key":"e_1_2_13_8_1","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2015.229"},{"key":"e_1_2_13_9_1","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2016.16"},{"key":"e_1_2_13_10_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10557-007-6035-1"},{"key":"e_1_2_13_11_1","doi-asserted-by":"publisher","DOI":"10.1038\/nature12174"},{"key":"e_1_2_13_12_1","doi-asserted-by":"publisher","DOI":"10.1179\/2045772314Y.0000000224"},{"key":"e_1_2_13_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2015.02.051"},{"key":"e_1_2_13_14_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11064-014-1510-0"},{"key":"e_1_2_13_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.brainres.2015.03.024"},{"key":"e_1_2_13_16_1","doi-asserted-by":"publisher","DOI":"10.1093\/hmg\/ddw029"},{"key":"e_1_2_13_17_1","doi-asserted-by":"publisher","DOI":"10.1073\/PNAS.2025102118"},{"key":"e_1_2_13_18_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.aaf6803"},{"key":"e_1_2_13_19_1","doi-asserted-by":"publisher","DOI":"10.1038\/nn.4608"},{"key":"e_1_2_13_20_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1714175114"},{"key":"e_1_2_13_21_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41573-020-0071-y"},{"key":"e_1_2_13_22_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2021.109112"},{"key":"e_1_2_13_23_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13075-021-02468-0"},{"key":"e_1_2_13_24_1","doi-asserted-by":"publisher","DOI":"10.1002\/prp2.365"},{"key":"e_1_2_13_25_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41583-018-0093-1"},{"key":"e_1_2_13_26_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41573-020-0071-y"},{"key":"e_1_2_13_27_1","doi-asserted-by":"publisher","DOI":"10.1002\/cpt.1615"},{"key":"e_1_2_13_28_1","doi-asserted-by":"publisher","DOI":"10.1111\/cts.12582"},{"key":"e_1_2_13_29_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jalz.2011.03.003"},{"key":"e_1_2_13_30_1","doi-asserted-by":"publisher","DOI":"10.3109\/21678421.2015.1049183"},{"key":"e_1_2_13_31_1","unstructured":"A study to evaluate the benefit and safety of GSK2982772 in moderate to severe psoriasis participants\u2013 Full Text View \u2013ClinicalTrials.gov. Accessed May 22 2021.https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04316585"},{"key":"e_1_2_13_32_1","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22041615"},{"key":"e_1_2_13_33_1","unstructured":"Denali therapeutics announces positive clinical results and regulatory progress for development programs in Amyotrophic Lateral Sclerosis (ALS). Accessed Jan 20 2022.https:\/\/www.globenewswire.com\/en\/news\u2010release\/2021\/10\/06\/2309876\/0\/en\/Denali\u2010Therapeutics\u2010Announces\u2010Positive\u2010Clinical\u2010Results\u2010and\u2010Regulatory\u2010Progress\u2010for\u2010Development\u2010Programs\u2010in\u2010Amyotrophic\u2010Lateral\u2010Sclerosis\u2010ALS.html"}],"container-title":["Clinical and Translational Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/cts.13317","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/cts.13317","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/ascpt.onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/cts.13317","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,22]],"date-time":"2023-08-22T12:59:59Z","timestamp":1692709199000},"score":1,"resource":{"primary":{"URL":"https:\/\/ascpt.onlinelibrary.wiley.com\/doi\/10.1111\/cts.13317"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6]]},"references-count":32,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2022,8]]}},"alternative-id":["10.1111\/cts.13317"],"URL":"https:\/\/doi.org\/10.1111\/cts.13317","archive":["Portico"],"relation":{},"ISSN":["1752-8054","1752-8062"],"issn-type":[{"value":"1752-8054","type":"print"},{"value":"1752-8062","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6]]},"assertion":[{"value":"2022-03-04","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-05-12","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-06-01","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}